CLOV Q1 2026 Earnings Strong EPS Surprise of 12876 Amid Revenue Uncertainty Recursion Pharmaceuticals Q1 2026 Earnings EPS Beat Amidst Pipeline Development ERO Q1 2026 Earnings EPS Surges Past Estimates Even as Copper Prices Weigh Atea Pharmaceuticals Q1 2026 Earnings Narrower Loss Beats Expectations Stock Edges Higher MRDN Q1 2026 Earnings Massive EPS Beat with 107647 Surprise Phreesia PHR Q1 2026 Earnings EPS Misses Estimates But Stock Gains on Positive Earnings Beat